期刊文献+

Role of ESR Pathway Genes in Breast Cancer: A Review

Role of ESR Pathway Genes in Breast Cancer: A Review
在线阅读 下载PDF
导出
摘要 Breast cancer is the leading cause of death in women. Prognosis of breast cancer is often pessimistic because the tumors are prone to metastasizing to the bone, brain, and lung. The estrogen signaling receptor (ESR) pathway contains 39 main genes and proteins which makes it one of the larger signaling pathways. Predominately this pathway and the proteins within are involved in breast growth and development, making it a prospective area of study for breast cancer. While the healthy ESR pathway has been constructed and is well established, a mechanistic model of mutated genes of ESR pathway has not been delved upon. Such mutated models could be utilized for selecting combinational targets for drug therapies, as well as elucidating crosstalk between other pathways and feedback mechanisms. To construct the mutated models of the ESR pathway it is imperative to assess what is currently understood in the literature and what inconsistencies exist in order to resolve them. Without this information, a model of the ESR pathway will be unreliable and likely unproductive. This review is the detailed literature survey of the biological studies performed on ESR pathways genes, and their respective roles in breast cancer. Furthermore, the details mentioned in the review can be beneficial for the integrated study of the ESR pathway genes, which includes, structural and dynamics study of the genes products, to have a holistic understanding of the cancer mechanism. Breast cancer is the leading cause of death in women. Prognosis of breast cancer is often pessimistic because the tumors are prone to metastasizing to the bone, brain, and lung. The estrogen signaling receptor (ESR) pathway contains 39 main genes and proteins which makes it one of the larger signaling pathways. Predominately this pathway and the proteins within are involved in breast growth and development, making it a prospective area of study for breast cancer. While the healthy ESR pathway has been constructed and is well established, a mechanistic model of mutated genes of ESR pathway has not been delved upon. Such mutated models could be utilized for selecting combinational targets for drug therapies, as well as elucidating crosstalk between other pathways and feedback mechanisms. To construct the mutated models of the ESR pathway it is imperative to assess what is currently understood in the literature and what inconsistencies exist in order to resolve them. Without this information, a model of the ESR pathway will be unreliable and likely unproductive. This review is the detailed literature survey of the biological studies performed on ESR pathways genes, and their respective roles in breast cancer. Furthermore, the details mentioned in the review can be beneficial for the integrated study of the ESR pathway genes, which includes, structural and dynamics study of the genes products, to have a holistic understanding of the cancer mechanism.
出处 《Advances in Breast Cancer Research》 2018年第2期134-186,共53页 乳腺癌(英文)
关键词 ESTROGEN Signaling Receptor (ESR) Pathway Breast Cancer ESR GENES Mechanistic Modeling Integrated Study KYOTO ENCYCLOPEDIA of GENES and GENOMES (KEGG) PubMed Literature Survey Estrogen Signaling Receptor (ESR) Pathway Breast Cancer ESR Genes Mechanistic Modeling Integrated Study Kyoto Encyclopedia of Genes and Genomes (KEGG) PubMed Literature Survey
  • 相关文献

参考文献2

二级参考文献11

  • 1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 2Arb-aroon Lertkhachonsuk,Cheng Har Yip,Thiravud Khuhaprema,Ding-Shinn Chen,Martyn Plummer,Sun Ha Jee,Masakazu Toi,Sarikapan Wilailak.Cancer prevention in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013[J].Lancet Oncology.2013(12)
  • 3Cheng-Har Yip,Nur Aishah Taib.Challenges in the management of breast cancer in low- and middle-income countries[J].Future Oncol.2012(12)
  • 4Hai-Rim Shin,Marie Clem Carlos,Cherian Varghese.Cancer Control in the Asia Pacific Region: Current Status and Concerns[J].Japanese Journal of Clinical Oncology.2012(10)
  • 5Danny R. Youlden,Susanna M. Cramb,Nathan A.M. Dunn,Jennifer M. Muller,Christopher M. Pyke,Peter D. Baade.The descriptive epidemiology of female breast cancer: An international comparison of screening, incidence, survival and mortality[J].Cancer Epidemiology.2012(3)
  • 6Nirmala Bhoo-Pathy,Cheng-Har Yip,Mikael Hartman,Cuno S.P.M. Uiterwaal,Beena C.R. Devi,Petra H.M. Peeters,Nur Aishah Taib,Carla H. van Gils,Helena M. Verkooijen.Breast cancer research in Asia: Adopt or adapt Western knowledge?[J].European Journal of Cancer.2012
  • 7C.R. Beena Devi,Tieng Swee Tang,Marilys Corbex.Incidence and risk factors for breast cancer subtypes in three distinct South‐East Asian ethnic groups: Chinese, Malay and natives of Sarawak, Malaysia[J].Int J Cancer.2012(12)
  • 8Joe B Harford.Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all[J].Lancet Oncology.2011(3)
  • 9C.H. Yip,N. Bhoo Pathy,C.S. Uiterwaal,N.A. Taib,G.H. Tan,K.S. Mun,W.Y. Choo,A. Rhodes.Factors affecting estrogen receptor status in a multiracial Asian country: An analysis of 3557 cases[J].The Breast.2011
  • 10Yan Liu Yue-Hui Li Feng-Jie Guo Jia-Jia Wang Rui-Li Sun Jin-Yue Hu Guan-Cheng Li.Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor α3 subunit[J].World Journal of Gastroenterology,2008,14(47):7175-7182. 被引量:9

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部